IBRX icon

ImmunityBio

200 hedge funds and large institutions have $212M invested in ImmunityBio in 2024 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 71 increasing their positions, 41 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
200
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$8.21M
Puts
$9.86M
Net Calls
Net Calls Change

Top Buyers

1 +$7.69M
2 +$7.68M
3 +$7.2M
4
Morgan Stanley
Morgan Stanley
New York
+$4.5M
5
BlackRock
BlackRock
New York
+$4.42M

Top Sellers

1 -$4.63M
2 -$3.28M
3 -$2.26M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$1.93M
5
First Trust Advisors
First Trust Advisors
Illinois
-$1.51M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$320K
52
$315K
53
$294K
54
$291K
55
$271K
56
$271K
57
$270K
58
$267K
59
$266K
60
$255K
61
$250K
62
$247K
63
$239K
64
$236K
65
$236K
66
$229K
67
$229K
68
$227K
69
$227K
70
$209K
71
$197K
72
$189K
73
$189K
74
$184K
75
$184K